drugset / Trial / NCT01434524
Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The long-term outcomes of branched-chain amino acid (BCAA) administration in patients undergoing hepatic resection remain unclear. The aim of this study is to assess the impact of oral supplementation with BCAA on the prevention for the development of liver tumorigenesis in patients undergoing liver resection.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-10
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Branched-chain Amino Acid | Other / unclassified | 13 g | Oral |